Kovitz Investment Group Partners, LLC Moderna, Inc. Transaction History

Kovitz Investment Group Partners, LLC

$23.6 Billion
Q3 2025

A detailed history of Kovitz Investment Group Partners, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Kovitz Investment Group Partners, LLC holds 12,080 shares of MRNA stock, worth $299,100. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,080

Previous 9,102 32.72%

Holding current value

$299,100

Previous $251,000 24.3%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	BUY	$23.51 - $34.67 $70,012 - $103,247	2,978 Added 32.72%	12,080 $312,000
Q2 2025 Aug 14, 2025	BUY	$23.65 - $28.54 $215,262 - $259,771	9,102 New	9,102 $251,000
Q4 2024 Aug 25, 2025	SELL	$36.85 - $63.93 $45,730 - $79,337	-1,241 Reduced 13.63%	7,861 $326,000
Q4 2024 Feb 14, 2025	SELL	$36.85 - $63.93 $1.51 Million - $2.62 Million	-40,925 Reduced 83.93%	7,838 $325,000
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $107,169 - $210,735	1,684 Added 3.58%	48,763 $3.26 Million

Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $1.16 Million - $1.92 Million	11,510 Added 32.36%	47,079 $5.59 Million
Q1 2024 May 14, 2024	BUY	$85.37 - $115.44 $96,468 - $130,447	1,130 Added 3.28%	35,569 $3.79 Million
Q4 2023 Feb 07, 2024	SELL	$69.51 - $104.43 $250,583 - $376,470	-3,605 Reduced 9.48%	34,439 $3.42 Million
Q3 2023 Nov 09, 2023	SELL	$96.41 - $126.61 $156,859 - $205,994	-1,627 Reduced 4.1%	38,044 $3.93 Million
Q2 2023 Aug 08, 2023	SELL	$118.5 - $160.53 $240,436 - $325,715	-2,029 Reduced 4.87%	39,671 $4.82 Million
Q1 2023 May 11, 2023	BUY	$135.66 - $197.02 $61,589 - $89,447	454 Added 1.1%	41,700 $6.4 Million
Q4 2022 Jan 19, 2023	BUY	$118.38 - $210.04 $110,922 - $196,807	937 Added 2.32%	41,246 $7.41 Million
Q3 2022 Nov 09, 2022	BUY	$118.07 - $194.18 $8,973 - $14,757	76 Added 0.19%	40,309 $4.77 Million
Q2 2022 Aug 02, 2022	BUY	$117.13 - $176.59 $106,822 - $161,050	912 Added 2.32%	40,233 $5.75 Million
Q1 2022 Apr 22, 2022	BUY	$126.46 - $235.05 $4.97 Million - $9.24 Million	39,321 New	39,321 $6.77 Million
Q3 2021 Oct 28, 2021	SELL	$221.9 - $484.47 $234,548 - $512,084	-1,057 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$129.91 - $234.98 $137,314 - $248,373	1,057 New	1,057 $248,000

Others Institutions Holding MRNA

# of Institutions

843

Shares Held

257M

Call Options Held

39.6M

Put Options Held

43.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $9.69B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovitz Investment Group Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kovitz Investment Group Partners, LLC with notifications on news.

Account

Kovitz Investment Group Partners, LLC Moderna, Inc. Transaction History